Press Release: Dupixent® late-breaking data from NOTUS confirmatory phase 3 COPD study presented at ATS and published in NEJM

Nitesh sinha May 20, 2024

https://ift.tt/ePwYfTG

from Sanofi - Aventis Groupe https://ift.tt/nrzsOaQ
via IFTTT

Post a Comment

0 Comments